What are the early warning signs of pancreatic cancer?
Pancreatic cancer does not show its signs and symptoms in its early stages. Only when it has grown large enough, it begins to exhibit its warning signs and symptoms.
But having these signs and symptoms does not necessarily mean that you have pancreatic cancer. They can be due to some other conditions. Hence, it is important to check with your doctor when you notice them.
- Jaundice (yellowing of the eyes and skin): Most people with pancreatic cancer have jaundice as one of their first symptoms. Darker urine, light-colored or greasy stools, and itchy skin are other signs and symptoms found in pancreatic cancer.
- Belly or back pain: Pain in the abdomen or back is common in pancreatic cancer. Belly pain is caused due to the large pancreatic tumors pressing on the surrounding organs. Back pain is due to the pressing of the large pancreatic mass on the nerves.
- Unintended weight loss
- Poor appetite
- Nausea and vomiting (usually worsened by eating)
- Enlarged gallbladder or liver
- Deep vein thrombosis or DVT (blood clots in a large vein, usually in the leg)
What are the types of pancreatic cancer?
Pancreatic cancer can be either of the two types:
- Exocrine pancreatic cancer: Cancer of a part of the pancreas (exocrine) that secretes enzymes that aid digestion
- Neuroendocrine pancreatic cancer: Cancer of a part of the pancreas (neuroendocrine) that secretes hormones such as insulin and glucagon
Pancreatic adenocarcinoma: More than 90% of cancers of the exocrine pancreas are adenocarcinomas.
Less common exocrine pancreatic cancers are:
- Adenosquamous carcinomas
- Squamous cell carcinomas
- Signet ring cell carcinomas
- Undifferentiated carcinomas
- Undifferentiated carcinomas with giant cells
Neuroendocrine pancreatic cancers, also known as endocrine or islet cell tumors are rare pancreatic tumors that make up for the rest 5% of pancreatic cancers.
What are the stages of pancreatic cancer?
The National Cancer Institute has classified the progression of pancreatic cancer into four stages ranging from I to IV with stage 0 being the earliest stage.
- Stage 0: Also known as carcinoma in situ, at this stage, cancer is found only in the upper layers of the pancreatic ducts. This stage cannot be identified by imaging tests or even by the naked eye.
- Stage I: Cancer has reached deeper into the pancreas. Stage one can be
- Stage IA: The tumor is ≤2 cm in size
- Stage IB: The tumor is >2 cm but ≤4 cm in size
- Stage II: Tumor size is > 4cm and cancer may have spread from the pancreas to lymph nodes or nearby organs.
- Stage IIA: Cancer has spread to nearby organs, but has not spread to nearby lymph nodes.
- Stage IIB: Cancer has spread to nearby lymph nodes and may have spread to other nearby organs.
- Stage III: Cancer has spread to the major blood vessels surrounding the pancreas and may have spread to nearby lymph nodes.
- Stage IV: Also known as end-stage pancreatic cancer or metastatic pancreatic cancer, this stage is characterized by the spread of cancer to other organs, such as the liver, lung, and bones.
Unlike many cancers, however, patients with pancreatic cancer are typically grouped into three categories:
- those with local disease,
- those with locally advanced, unresectable disease, and
- those with metastatic disease.
Initial therapy often differs for patients in these three groups.
What is the survival rate for pancreatic cancer?
Pancreatic cancer is the ninth most common cancer in women and the tenth most common cancer in men. It is the fourth leading cause of cancer deaths in men and women.
The five-year survival rate tells you what percent of people live at least five years after the cancer is found. The general five-year survival rate for people with pancreatic cancer is 9% i.e., only nine out of every 100 patients of pancreatic cancer will survive for at least five years.
Survival rates and individual outcomes are based on many factors, including the stage of cancer and response of the patient to cancer therapy.
- Early-stage pancreatic cancer (cancer present only in the pancreas)/Stage I: The five-year survival rate is 37%.
- Pancreatic cancer that has spread to surrounding tissues or organs/Stage II and Stage III: The five-year survival rate is 12%.
- Pancreatic cancer that has spread to a distant organ of the body (metastasis)/Stage IV: The five-year survival rate is 3%.
Latest Cancer News
Daily Health News
Health Solutions From Our Sponsors
Pancreatic Cancer. Available at: https://www.medicinenet.com/pancreatic_cancer/article.htm
Pancreatic Cancer Treatments by Stage. Available at: https://www.webmd.com/cancer/pancreatic-cancer/pancreatic-cancer-treatments-stage#1
Pancreatic Cancer Guide. Available at: https://www.cancer.net/cancer-types/pancreatic-cancer
Top Early Warning Signs of Pancreatic Cancer Related Articles
Cancer 101 SlideshowLearn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read about the common type of cancers.
Guide to LeukemiaLearn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer are living longer than ever, and it may be curable.
Top Cancer-Fighting FoodsExperts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help reduce your risk of developing cancer.
Cancer QuizTake this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most common cancers.
Detectnet (copper Cu 64 dotatate)Detectnet (copper Cu 64 dotatate) binds to somatostatin receptors that are the hallmark of neuroendocrine tumors (NETs). Detectnet settles in the tissues and the tumor receptors absorb it. The copper molecules act as a radioactive beacon that doctors can see on a PET scan image. Based upon the intensity of the signals, PET images obtained using copper Cu 64 dotatate injection indicate the presence and density of somatostatin receptors, showing neuroendocrine tumors in the body as a result.
Is Pancreatic Cancer Back Pain Constant?Cancer of the the pancreas is called pancreatic cancer. Pain in the upper abdomen and back is commonly seen in those who have pancreatic cancer. The back pain is generally not constant.
Lynparza (olaparib)Lynparza is a prescription medicine used to treat adults who have advanced ovarian cancer, fallopian tube cancer, primary peritoneal cancer, a certain type of abnormal inherited BRCA gene, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, or metastatic pancreatic cancer with a certain type of abnormal inherited BRCA gene. The most common side effects of Lynparza are nausea or vomiting.
Pancreatic CancerPancreatic cancer is a malignant tumor of the pancreas. Pancreatic cancer has been called a "silent" disease because early pancreatic cancer usually does not cause early symptoms. Typically, pancreatic cancer has metastasized (spread to adjacent organs, such as the liver) by the time most people receive a dignosis of pancreatic cancer. Symptoms and signs usually appear later in the course of the disease and include jaundice, back pain, nausea, weight loss, itching, and loss of appetite. Treatment depends upon the type of pancreatic cancer but may include surgery, chemotherapy, and/or radiation therapy.
Pancreatic Cancer PictureAn abdominal CT scan shows a small, vaguely seen 2-cm pancreatic adenocarcinoma (mass) causing obstruction of both the common bile duct (cbd) and pancreatic duct (pd). See a picture of Pancreatic Cancer and learn more about the health topic.
Pancreatic Cancer Symptoms, Causes, and TreatmentLearn about pancreatic cancer signs, symptoms, causes, statistics, treatments (chemotherapy, radiation, surgery, biological therapy) and their side effects on of malignant tumors of the pancreas.
Targeted Therapy: What Drugs Target the Tumor Microenvironment?Some targeted cancer therapies aim at the pro-survival factors in the tumor microenvironment. The tumor microenvironment is the surrounding tissue, known as stroma, which provides the support for cancer's growth and survival. Targeted cancer therapy is a specialized cancer treatment targeting specific cellular mechanisms that give rise to cancer and help its metastasis.
Udenyca (pegfilgrastim-cbqv)Udenyca (pegfilgrastim-cbqv) is a prescription medicine used to treat the symptoms of Hematopoietic Subsyndrome of Acute Radiation Syndrome and prevention of chemotherapy-induced Neutropenia. Serious side effects of Udenyca include hives, difficulty breathing, swelling of your face, lips, tongue, or throat; skin rash, sweating, dizziness, warmth or tingly feeling, wheezing, decreased urination, tiredness, lightheadedness, sudden swelling, and others.
What Is the #1 Cause of Pancreatic Cancer?Pancreatic cancer occurs when cells begin to grow uncontrollably and form tumors within the pancreas. The exact cause of pancreatic cancer is unknown. However, doctors have identified some risk factors that increase your chances of developing pancreatic cancer. These include being over 45 years old, male gender, African American race, cigarette smoking, alcohol abuse, regular consumption of high dietary fats, obesity, type 2 diabetes, chronic pancreatitis, family history of pancreatic cancer, and heavy exposure to certain chemicals used in the dry cleaning and metalworking industries.